@jvisserlabs it's weird coming from you, with all the research you've done on A.i... you loved $PLTR in the 170's . I guess you didn't see it coming, oh well there is always that great call last year on $BTC..
🥐RUMBS 👇
With $APLS being taken out overnight for a $ñ150% premium…
Soleno Therapeutics $SLNO should be next…
They’ve already penetrated >1.25k of the 10k patients in the US & should 2x that in the next year…
That would be $6-8/share in FCF!!
And W/ $500 mil in 💰, that’san enterprise value of only $23/share.
The ultimate annual opportunity is 5k-7k patients 👇.
& the ONLY competitor was a competing drug from Aardvark [$AARD] which was halted for safety…leaving $SLNO as the ONLY 💊 option.
It’s just a ❓ of how quickly theyre going to ramp to $16/share in FCF.
It may be the cheapest stock in the whole market w/ M&A in the sector 🔥 up…
(*Not investment advice- Donyour own research…I own the stock 🤑)